Empirical Bioscience announced today that their QuanTASE and QuanTASE PLUS One Step RT-qPCR RT-qPCR Kits have been successfully tested in assays using EUA authorized qPCR detection kits using the established CDC testing protocol.
The test amplifies and identifies genetic material from the SARS-CoV-2 virus that causes COVID-19 in one step. The QuanTASE RT-qPCR Assay Kits works by converting the CoV-2 RNA into DNA and amplifying to detect the presence of pathogenic material in patient samples.
In addition to its efficient design, the kit operates on most existing laboratory testing equipment in the United States, and it includes all of the required RT-qPCR reaction reagents needed to run a COVID-19 test. It also meets the performance requirements for nCoV-2 testing established by the Centers for Disease Control (CDC) when used in accordance with CDC guidelines and in conjunction with an approved detection kit.